Sustained Benefits from Ranibizumab for Central Retinal Vein Occlusion with Macular Edema: 24-Month Results of the CRYSTAL Study

Michael Larsen*, Sebastian M. Waldstein, Siegfried Priglinger, Philip Hykin, Elizabeth Barnes, Margarita Gekkieva, Ayan Das Gupta, Andreas Wenzel, Jordi Monés, CRYSTAL Study Group

*Corresponding author af dette arbejde
36 Citationer (Scopus)

Fingeraftryk

Dyk ned i forskningsemnerne om 'Sustained Benefits from Ranibizumab for Central Retinal Vein Occlusion with Macular Edema: 24-Month Results of the CRYSTAL Study'. Sammen danner de et unikt fingeraftryk.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience